248 related articles for article (PubMed ID: 20196656)
1. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
Jeong KI; Tzipori S; Sheoran AS
J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
[TBL] [Abstract][Full Text] [Related]
2. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.
Melton-Celsa AR; Carvalho HM; Thuning-Roberson C; O'Brien AD
Clin Vaccine Immunol; 2015 Apr; 22(4):448-55. PubMed ID: 25716230
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterization of shiga toxin-producing Escherichia coli in swine feces recovered in the National Animal Health Monitoring System's Swine 2000 study.
Fratamico PM; Bagi LK; Bush EJ; Solow BT
Appl Environ Microbiol; 2004 Dec; 70(12):7173-8. PubMed ID: 15574914
[TBL] [Abstract][Full Text] [Related]
7. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
[TBL] [Abstract][Full Text] [Related]
8. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Karmali MA; Sarkim V; Bobrowski C; Petric M; Karch H; Müller-Wiefel DE;
J Clin Microbiol; 2001 Jun; 39(6):2272-9. PubMed ID: 11376069
[TBL] [Abstract][Full Text] [Related]
10. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
[TBL] [Abstract][Full Text] [Related]
11. New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.
Skinner C; Patfield S; Stanker LH; Fratamico P; He X
PLoS One; 2014; 9(6):e99854. PubMed ID: 24914553
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.
Ritchie JM; Wagner PL; Acheson DW; Waldor MK
Appl Environ Microbiol; 2003 Feb; 69(2):1059-66. PubMed ID: 12571029
[TBL] [Abstract][Full Text] [Related]
14. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
[TBL] [Abstract][Full Text] [Related]
16. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.
Rocha LB; Luz DE; Moraes CT; Caravelli A; Fernandes I; Guth BE; Horton DS; Piazza RM
Toxins (Basel); 2012 Sep; 4(9):729-47. PubMed ID: 23105978
[TBL] [Abstract][Full Text] [Related]
18. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
19. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic characteristics of non-O157 Shiga toxin-producing Escherichia coli (STEC) from Swiss cattle.
Zweifel C; Schumacher S; Blanco M; Blanco JE; Tasara T; Blanco J; Stephan R
Vet Microbiol; 2005 Jan; 105(1):37-45. PubMed ID: 15607082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
